| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39c3a06706e79b48ef4d7b444ec7faaf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-745 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2005-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04dee109bfefcfb960c864a271c94c32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e299b09676982ebcb56ac7f0146fed76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38be8b4a8586128c56fe3e6feefef762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f098ac801a1f08a7519d77b4968a889b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79b85a24fa11b30f2094368a9f4b0b77 |
| publicationDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2594289-A1 |
| titleOfInvention |
Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| abstract |
A monoclonal antibody to soluble fibrin that is capable of specifically recognizing a structural change site newly occurring in the C-terminal region of A.alpha.-chain of soluble fibrin formed by thrombin digestion of fibrinogen; a hybridoma capable of producing the antibody; an immunological assay method using the antibody; and a method of estimating any hypercoagulable state of test specimen through assay of soluble fibrin contained in the test specimen by the immunological assay method. The use of this monoclonal antibody would realize specific detection of any soluble fibrin reflecting only an initial hypercoagulability and not being acted on by plasmin. |
| priorityDate |
2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |